” Re: Testosterone Replacement Therapy and the Risk of Adverse Cardiovascular Outcomes and Mortality .” The Journal of Urology, 203(1), pp. 14–15 © 2020 by American Urological Association Education and Research, Inc.
Purpose:Defining prostate cancer contours is a complex task, undermining the efficacy of interventions such as focal therapy. A multireader multicase study compared physicians’ performance using…
Purpose:The Prostate Imaging Reporting and Data System (PI-RADS) score is standard of care for clinically significant prostate cancer (csPCa) diagnosis. The PRIMARY score (prostate-specific membrane…
AbstractIntroduction:We sought to estimate per patient and annual aggregate health care costs related to metastatic prostate cancer.Methods:Using the Surveillance, Epidemiology, and End Results-Medicare database, we…
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Introduction:Patient preference assessment is key to high-quality decision-making in men with prostate cancer. We aimed to determine if “phenotypes” could be identified among men with…
Purpose:Our goal was to assess acute autonomic nervous system (ANS) response to direct sacral nerve root (SNR) stimulation in the context of lower urinary tract…
Purpose:We aimed to evaluate the therapeutic efficacy and safety of TAS-303, a highly selective noradrenaline reuptake inhibitor, in Japanese women with stress urinary incontinence (SUI).Materials…
Introduction:Patient preference assessment is key to high-quality decision-making in men with prostate cancer. We aimed to determine if “phenotypes” could be identified among men with…
Purpose:Nonmuscle-invasive bladder cancer (NMIBC) has high recurrence rates and is often treated with mitomycin C (MMC) and bacillus Calmette-Guérin (BCG). Their efficacy relies on phase…
